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Abstract
Objective: Congenital heart diseases (CHD) frequently occur in children with Down syndrome. A few 
studies in Nigeria have highlighted the pattern of CHD in such patients, but results are variable with no 
data from the study area for comparison. This study aims to determine the pattern of CHD among children 
with Down syndrome as seen at UDUTH, Sokoto 
stMethods: A prospective study conducted between 1st October 2011 and 31 April 2015. Subjects included 
all children with phenotypic features of Down syndrome (DS) who were seen at the Pediatric cardiology 
clinic and had echocardiography diagnosis of congenital heart diseases. 
Results: Of the 41 cases of DS seen during the study period, 32 (78.0%) children aged 2 weeks to 22 
months (Mean +SD = 5.6 ± 4.0 months) were diagnosed with CHD. Male to female ratio was 2.2:1. 
Atrioventricular septal defect (AVSD) was the commonest CHD seen in 18 (56.3%) patients. Nine 
(28.1%) patients had isolated ventricular septal defect (VSD), three (9.4%) had VSD coexisting with atrial 
septal defect (ASD) while one (3.1%) patient each had isolated ASD and Fallot's tetralogy respectively. 
Only three (9.4%) patients had surgical closure abroad, with good postoperative outcome in two of the 
patients. 
Conclusion: AVSD is the commonest CHD in our series, which is similar to previous reports. Increased 
access to definitive intervention is advocated since surgical outcome in such patients may be favorable. 
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Résumé
Objectif: les maladies cardiaques congénitales (CHD) se produisent fréquemment chez les enfants 
atteints du syndrome de Down. Quelques études au Nigeria ont mis en évidence le modèle de la maladie 
coronarienne chez ces patients, mais les résultats sont variables sans données de la zone d'étude pour la 
comparaison. Cette étude vise à déterminer le motif de la maladie coronarienne chez les enfants atteints du 
syndrome de Down comme on le voit à UDUTH, Sokoto
Méthodes: Une étude prospective menée entre le 1er Octobre 2011 et 31stApril 2015. Les sujets inclus 
tous les enfants avec des caractéristiques phénotypiques du syndrome de Down (DS) qui ont été vus à la 
clinique de cardiologie pédiatrique et ont eu un diagnostic de l'échocardiographie de maladies cardiaques 
congénitales.
Résultats: Sur les 41 cas de DS vu au cours de la période d'étude, 32 (78,0%) des enfants âgés de 2 
semaines à 22 mois (moyenne + SD = 5,6 ± 4,0 mois) ont été diagnostiqués avec la maladie coronarienne. 
Homme ratio était de 2,2: 1. Atrioventricular défaut septal (CAV) a été le CHD fréquente vu dans 18 
(56,3%) patients. Neuf (28,1%) patients avaient isolé défaut septal ventriculaire (CIV), trois (9,4%) avait 
VSD coexistant avec défaut auriculaire septal (ASD) ASD tandis que l'un (3,1%) des patients chacun avait 
isolé et la tétralogie de Fallot, respectivement. Seulement trois (9,4%) patients ont eu la fermeture 
chirurgicale à l'étranger, avec un bon résultat postopératoire chez deux des patients.
Conclusion: CAV est la plus fréquente CHD dans notre série, qui est similaire aux précédents rapports. 
Un accès accru à l'intervention définitive est préconisée depuis résultat chirurgical chez ces patients peut 
être favorable.
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INTRODUCTION 
Down syndrome is the commonest 
chromosomal abnormality in humans, with an 
incidence of 1 in 1,000 to 1 in 1,100 live births 
worldwide . First recognized by John Langdon 
Down in 1866, this genetic disorder is primarily 
caused by chromosomal non-disjunction, 
resulting in trisomy 21 . It is usually diagnosed on 
the basis of typical phenotypic features  and this 
 is confirmed by Karyotyping. Some of the 
phenotypic features of this syndrome include 
hypertelorism, depressed nasal bridge, medial 
epicanthic folds, low set ears, upward slanting 
palpebral fissures, single transverse palmar 
crease, clinodactyly and hypotonia. In addition, 
mul t ip le  organ sys tems such as  the  
cardiovascular, gastrointestinal, hematologic, 
endocrine and central nervous systems may be 
involved to a variable degree . Cardiovascular 
manifestations in form of congenital heart 
disease (CHD) occurs in up to 40-60% of the 
patients and is responsible for most of the 
morbidity and mortality in children with Down 
syndrome . Hence, early recognition of these 
lesions and timely intervention will improve the 
life expectancy and quality of life in affected 
children and reduce the emotional stress faced by 
their parents/caregivers.
Previous studies have described the pattern of 
congenital heart defects in children with Down 
syndrome (DS), but results are variable. While 
atrioventricular canal defect (AVCD) was found 
 to be the most common lesion by some studies ,
others have reported ventricular septal defect 
 (VSD) and patent ductus arteriosus (PDA)  as 
most prevalent among their study patients. 
Similarly, conflicting results have been reported 
regarding the outcome of surgery for congenital 
heart diseases in children with DS,  with some of 
the recent studies showing no evidence of 
increased mortality in such patients . In resource-
limited countries where access to cardiac surgery 
 
is difficult and frequently delayed, the outcome 
may be less favorable compared to that in the 
general population. This is because patients with 
DS are more prone to early development of 
pulmonary hypertension, which may adversely 
affect surgical outcome. 
There is presently no data from the study 
area on the pattern and outcome of congenital 
heart disease among children with Down 
syndrome. Hence, this study was conducted to 
determine the pattern and outcome of CHDs 
among children with phenotypic features of 
Down syndrome attending the Paediatric 
Cardiology clinic of Usmanu Danfodiyo 
University Teaching Hospital, Sokoto. Such 
information is needed for comparison with other 
studies and to guide management of patients who 
present to the study area.
MATERIALS AND METHODS  
Study area: This study was conducted at the 
Paediatric Department of Usmanu Danfodiyo 
University Teaching Hospital (UDUTH), 
Sokoto, Northwestern Nigeria. The Hospital is 
multidisciplinary and caters for a large number of 
patients within the sub-region and from 
neighbouring countries such as Niger and Benin 
Republics. 
Study design: This was a prospective study 
conducted between 1st October 2011 and 
st
31 April 2015. 
Study subjects: Subjects included all children 
with phenotypic features of Down syndrome 
(DS), who were seen at the Paediatric Cardiology 
clinic and had echocardiographic diagnosis of 
congenital heart disease. Excluded from the study 
were: patients older than 15years (Paediatric age 
limit at UDUTH), children who already had 
definitive surgery at first presentation and those 
who died before diagnosis of cardiac lesion could 
be confirmed by echocardiography. Patients who 
satisfied the eligibility criteria were recruited 
consecutively after getting informed written 
consent from the caregivers and/or assent for 
children aged more than seven years. The study 
was approved by the Hospital Ethics Committee
Procedure: At presentation, demographic 
information such as age, gender, mobile phone 
numbers were obtained. Each patient had detailed 
general examination including inspection for 
presence of dysmorphic features of Down 
syndrome, measurement of anthropometric 
indices and pulse oxygen saturation, as well as 
cardiovascular evaluation. Thereafter, the 
patients had Chest-X ray and then 12-lead 
Electrocardiography (ECG). The latter was 
performed by an ECG technician using Dr-Lee 
ECG machine (Model 310A, Italy), which was 
fitted with paediatric ECG probes. For children 
that were not cooperative, light sedation was 
achieved by oral administration of chloral 
hydrate at a dose of 50mg/kg. Results of the ECG 
tracings were read by the principal author.
E c h o c a r d i o g r a p h y :  T r a n s t h o r a c i c  
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Echocardiography (TTE) was performed using 
Sonoscape SSI 5000 echo-machine, mounted 
with a 2.5MHz linear array transducer. Cardiac 
imaging was through apical, parasternal long axis 
(PLAX), parasternal short axis (PSAX), 
subcostal and suprasternal notch views. The 
location and size of anatomic defects were 
d e t e r m i n e d  u s i n g  2 - d i m e n s i o n a l -
echocardiography (2D); whereas flow direction 
and pressure gradients were assessed with colour 
Doppler and continuous wave Doppler 
respectively. M-mode was used for measurement 
of ventricular function. Echocardiographic 
evaluation was performed by the principal 
investigator, who had previously underwent one 
year post fellowship training in Pediatric 
Cardiology at India and has had more than 5 years 
working experience in Pediatric Cardiology Unit 
of UDUTH, Sokoto. 
Treatment and follow up: All parents/guardians 
of children with confirmed CHD were counseled 
accordingly. The need for surgery, where 
necessary, was discussed with the parents or 
guardians. When indicated, medical treatment 
with anti-heart failure medications (Frusemide, 
spironolactone and captopril), antibiotics for 
concomitant respiratory infections and 
nutritional rehabilitation were commenced. 
Patients were followed up after hospital 
discharge at the paediatric cardiology clinic. 
Those with other identified co-morbidities such 
as neurologic abnormalities were also referred to 
appropriate specialty clinics for evaluation and 
follow up. 
Data analysis: The demographic, clinical and 
echocardiography data of all the patients with 
confirmed congenital heart diseases were entered 
and analyzed using SPSS statistical software 
version 20 (Armonk, NY: IBM Corp). 
Quantitative data were expressed as means and 
standard deviation while categorical variables 
were expressed as proportions. The proportions 
of male and female subjects across various age 
groups were compared using Chi-square test 
while Fishers exact test was used to compare 
children with AVSD and those with other lesions. 
A p-value of <0.05 was considered statistically 
significant.  
RESULTS
Demographic and clinical characteristics of 
patients
A total of 41 children with phenotypic 
features of Down syndrome were seen at the 
paediatric cardiology clinic during the study 
period. Thirty-two (78.0%) of these had 
echocardiographic diagnosis of Congenital heart 
disease (CHD). There were 22 males and 10 
females (M: F ratio= 2.2:1). The mean +SD age 
was 5.6 ± 4.0 months (range 2weeks to 22 
months), while mean maternal age was 31.4 + 6.8 
years (range 18-42 years). Table 1 shows the age 
and gender distribution of children with DS and 
congenital heart disease. Majority of them 
(62.5%) were under the age of six month.
The patients presented with various 
symptoms including difficulty in breathing, 
cough, failure to thrive and bluish discoloration 
of the lips and tongue. However, 3(9.4%) patients 
were asymptomatic (table 2). 
Pattern of CHD
Acyanotic congenital heart diseases 
(ACHDs) accounted for 96.9% of all congenital 
heart diseases while cyanotic CHD constituted 
only 3.1% of the cases. The spectrum of the 
various lesions among the study cohort is shown 
in table 3. Atrioventricular septal defect (AVSD) 
was the commonest congenital cardiac defect, 
with a prevalence of 56.3%. Ventricular septal 
defect (VSD) was the next most common CHD, 
occurring in isolation (28.1%) or in association 
with atrial septal defect (9.4%). Tetralogy of 
Fallot (TOF) was the only cyanotic CHD 
observed among the study subjects and occurred 
in one patient (3.1%) only. Of the 18 children 
with AVSD, 7 (38.9%) were females compared to 
only 3 (21.4%) females out of the 14 children 
diagnosed with other congenital heart lesions. 
However, the difference was not statistically 
significant (Fisher's Exact Test, p= 0.45). Figure 
1 shows a 2-dimensional echocardiographic 
image of one of the study patients with complete 
AVSD.
Treatment and outcome:
Three of the 32 (9.4%) patients had 
surgical intervention at India (AVSD repair in 2 
and VSD closure in one patient); while one 
patient (3.1%) had spontaneous closure of VSD. 
Nine patients (28.1%) were lost to follow up 
while the remaining 19 (59.4%) patients are still 
on follow up at both the Pediatric Cardiology and 
Pediatric Neurology clinics. The two patients that 
had surgery for atrioventriuclar septal defect 
(AVSD) were aged 14 and 22 months 
respectively while the third patient who had VSD 
repair was 9 months old. Though surgery was 
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successfully performed in all the patients, they all 
had prolonged post operative hospital stay. 
Unfortunately, the 22-month-old girl that had 
AVSD repair developed severe postoperative 
pulmonary artery hypertension (PAH) and 
subsequently died at India. 
DISCUSSION 
Congenital heart diseases are recognized 
as one of the most common systemic co-
morbidities in children with Down syndrome . 
The present study has found a high prevalence of 
CHDs (79.3%) among children with Down 
syndrome. This finding is comparable to that of 
Asani et al  in Kano, Northwestern Nigeria, 
which reported a prevalence of 77.1% among the 
35 subjects evaluated. Ekure et al  in Lagos has 
similarly reported a prevalence of 87% among a 
cohort of 54 subjects with Down syndrome 
 
whereas Otaigbe et al in Port Harcourt, reported 
the highest prevalence of 100% among 38 
subjects studied. The very high prevalence 
obtained in the latter study is not clear, but high 
rates of exposure to environmental toxins due to 
petroleum exploration activities in the region has 
been suggested as one of the possible 
explanations . 
It is of note that the aforementioned 
studies (5,7,10) were hospital based and might 
therefore over-estimate the prevalence of CHDs 
in children with Down syndrome. This is because 
symptomatic children with suggestive symptoms 
of CHDs are more likely to be referred to the 
hospital than those who are otherwise normal or 
asymptomatic. Consequently, hospital sample 
may not represent the actual community burden 
and pattern of CHDs in patients with DS. 
Population-based prevalence of CHDs in 
children with this chromosomal anomaly has 
been shown to be generally lower (ranging 
between 40-60%) than hospital-derived estimate 
. A community study in Brazil,  for example, 
reported a prevalence of 46.8% among children 
diagnosed with DS. Hence, as suggested by 
 
Freeman et al, true estimation of the prevalence 
and types of heart defects in Down syndrome 
should be done using a population-based sample. 
This is however difficult in developing countries, 
where health and birth records are not optimal. 
The pattern of CHD in the study cohort 
showed preponderance of acyanotic lesions, as 
only one patient had cyanotic CHD in form of 
 tetralogy of Fallot. Like many other studies,  
atrioventricular septal defect (AVSD) was the 
commonest type of CHD in the present study. 
This is in contrast to some studies that found other 
  
lesions to be the most common . Ekure in Nigeria 
, and both Abbag  and Al-Jarallah  in Saudi 
Arabia have reported ventricular septal defect 
(VSD) as the most common heart defect in 
children with Down syndrome; whereas some 
studies in Brazil  and in Turkey  have both 
demonstrated atrial septal defect (ASD) as the 
commonest lesion among their study cohorts. 
Curiously, patent ductus arteriosus (PDA) was 
the most frequent in a study by Otaigbe et al  in 
Port Harcourt, South-South Nigeria. The results 
from these studies highlight the wide variability 
in the pattern and prevalence of cardiac lesions 
among children with DS. Whether this variability 
could be related to geographic, genetic or other 
epidemiologic factors need to be further 
explored.  
More than 60% of the patients were 
diagnosed below the age of six months, which is 
 consistent with reports from other studies . This 
may imply that such patients do come to light 
relatively early due to obvious dysmorphic 
features or early onset of clinical symptoms as a 
result of their congenital heart defects or other 
associated comorbidities. It has been advocated 
that all newborn infants with features of Down 
syndrome should have early cardiac evaluation to 
exclude congenital heart defects . This is because 
of the risk for early onset pulmonary vascular 
disease in such patients,  which may 
contraindicate surgery and adversely affect their 
prognosis . 
Due to the small number of patients, it is 
difficult to reliably compare the gender variations 
in the relative prevalence of specific cardiac 
lesions among the study subjects. The higher 
number of males with CHD as well as AVSD in 
this study may be due to the preponderance of 
male subjects with DS compared to females.  
Asani et al  in their study of children with DS, 
have shown a higher prevalence of CHD in males 
with DS than female subjects whereas; Otaigbe et 
al  in Port-Harcourt reported equal incidence in 
both genders. But these studies were also limited 
by small sample size. 
Access to definitive intervention was 
very low among the study patients, as only three 
of them were able to afford the cost of surgery at 
India. The challenges of cardiac surgery in 
Nigeria and indeed many parts of Africa have 
 
previously been highlighted . These include 
endemic poverty, high cost of surgery, poorly 
equipped health facilities and lack of personnel 
with capacity to offer routine cardiac intervention 
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locally . In the past, the benefit of cardiac surgery 
 
in children with Down syndrome was doubted 
and some caregivers may be unwilling to spend 
their resources on a condition in which the other 
associated neurologic and physical features may 
not be amenable to treatment . It has now been 
shown that such intervention is associated with 
actuarial survival benefit and improved quality of 
life . In the present study, all the three patients that 
had surgery had prolonged postoperative hospital 
stay, but death occurred in one of the patients who 
was aged 22 months at the time of surgery. The 
other two patients have remained stable on follow 
up. Hence, unless where contraindicated, Down 
children with CHD should have timely correction 
of their cardiac lesions to enhance prognosis. 
Concerted effort to urgently make cardiothoracic 
surgical services locally available and accessible 
is necessary. 
CONCLUSION
This study has shown a high prevalence of CHD 
in children with Down syndrome, with AVSD 
being the most common type of heart lesion. 
Majority of the affected patients have limited 
access to definitive treatment, emphasizing the 
need to establish functional cardiac centers in the 
country. There is need for multicenter 
population-based studies in the country to 
ascertain the actual community prevalence and 
types of CHDs in children with Down syndrome.
Study limitations: Being a hospital-based study 
with small sample size, the result may not be truly 
representative of the population in the study area. 
Karyotyping was performed in only two patients, 
as facilities for such investigation were presently 
not available locally. The number of patients that 
had surgery is too small to allow for meaningful 
statistical analysis of surgical outcome.
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Table 1: Age and gender distribution of children with Down syndrome and CHD 
Age (Months)  Male n (%) Female n (%)  Total n (%) 
0-6 14 (70.0) 6 (30.0) 20 (62.5) 
6.1-12  6 (66.7) 3 (33.3) 9 (28.1) 
>12  2 (66.7) 1 (33.3) 3 (9.4) 
Total  22 (68.8) 10 (31.2) 32 (100.0) 
x2= 0.39 df=2, p= 0.98 
 
 
Table 2: Presenting symptoms in  children with Down syndrome and CHD  
*Presenting symptoms  n (%) 
Cardiac murmur 31 (96.9) 
Cough  26 (81.3) 
Poor weight gain  19 (59.4) 
Delayed motor milestones    14 (43.8) 
Asymptomatic    3  (9.4) 
Cyanosis     2 (6.3) 




Table 3: Spectrum of congenital heart diseases seen in children with Down syndrome 
Type of CHD Male n (%) Female n (%) Total n (%) 
Atrioventricular Septal Defect (AVSD)  11 (61.1) 7(38.9) 18(56.3) 
Isolated Ventricular Septal D efect 7 (77.8) 2(22.2) 9(28.1) 
VSD + ASD 2(66.7) 1(33.3) 3(9.4) 
Isolated Ostium Primum ASD 1(100.0) 0(0.0) 1(3.1) 
Tetralogy of Fallot  1(100.0) 0(0.0) 1(3.1) 
Total 22(68.8) 10(31.2) 32(100.0) 
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Figure 1: A 2 dimensional echo of a 10 -month old girl  
with Down syndrome showing complete atrioventricular  
septal defect (see arrow showing the central defect).  
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